Intuitive Surgical (ISRG) Set to Announce Earnings on Thursday

Intuitive Surgical (NASDAQ:ISRG) will be posting its quarterly earnings results after the market closes on Thursday, April 18th. Analysts expect Intuitive Surgical to post earnings of $1.40 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The company had revenue of $1.93 billion for the quarter, compared to analysts’ expectations of $1.89 billion. During the same quarter in the previous year, the business posted $0.91 EPS. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. On average, analysts expect Intuitive Surgical to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $388.46 on Thursday. The stock has a market cap of $137.69 billion, a PE ratio of 77.23, a price-to-earnings-growth ratio of 6.01 and a beta of 1.36. The stock’s 50-day moving average is $388.07 and its two-hundred day moving average is $339.29. Intuitive Surgical has a fifty-two week low of $254.85 and a fifty-two week high of $403.76.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. Stifel Nicolaus boosted their price target on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday. Raymond James upped their price target on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Wells Fargo & Company upped their price target on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Citigroup upped their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Piper Sandler upped their target price on Intuitive Surgical from $325.00 to $425.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $375.70.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the sale, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of the firm’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the transaction, the executive vice president now directly owns 189 shares in the company, valued at $69,958.35. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $397.07, for a total value of $2,001,629.87. Following the completion of the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 248,418 shares of company stock valued at $95,927,097. 0.80% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 30,375,494 shares of the medical equipment provider’s stock worth $10,247,477,000 after acquiring an additional 507,267 shares during the period. Geode Capital Management LLC boosted its stake in Intuitive Surgical by 1.0% in the 1st quarter. Geode Capital Management LLC now owns 6,444,995 shares of the medical equipment provider’s stock valued at $1,642,287,000 after purchasing an additional 61,659 shares during the period. Morgan Stanley boosted its stake in Intuitive Surgical by 29.9% in the 4th quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock valued at $1,556,706,000 after purchasing an additional 1,351,002 shares during the period. Norges Bank bought a new stake in Intuitive Surgical in the 4th quarter valued at $915,360,000. Finally, Nuveen Asset Management LLC boosted its stake in Intuitive Surgical by 3.1% in the 4th quarter. Nuveen Asset Management LLC now owns 3,405,120 shares of the medical equipment provider’s stock valued at $1,148,751,000 after purchasing an additional 101,680 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.